Figure 3.
Relative mRNA expression levels of genes for estrogen-metabolizing enzymes in abdominal subcutaneous (Sc) and visceral (Visc) AT. *P ≤ 0.05; #P ≤ 0.01; subcutaneous vs visceral AT (Wilcoxon signed rank test, n = 12). Data are expressed as median (interquartile range) and represent relative expression levels. CYP19A1, aromatase; HSD17B2, HSD17B7, and HSD17B12, hydroxysteroid 17-β dehydrogenase 2, 7, and 12.

Relative mRNA expression levels of genes for estrogen-metabolizing enzymes in abdominal subcutaneous (Sc) and visceral (Visc) AT. *P ≤ 0.05; #P ≤ 0.01; subcutaneous vs visceral AT (Wilcoxon signed rank test, n = 12). Data are expressed as median (interquartile range) and represent relative expression levels. CYP19A1, aromatase; HSD17B2, HSD17B7, and HSD17B12, hydroxysteroid 17-β dehydrogenase 2, 7, and 12.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close